Losartan Bromo N2-Trityl Impurity

Product Description
CAT No.
ALN-L028021
CAS No.
133051-88-4
Mol. F.
C33H25BrN4
Mol. Wt.
557.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 5-(4′-(Bromomethyl)(1,1′-biphenyl)-2-yl)-2-trityl-2H-tetrazole
Smiles : BrCC1=CC=C(C2=CC=CC=C2C3=NN(C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)N=N3)C=C1
Inchi : InChI=1S/C41H35ClN6O/c1-2-3-23-38-43-39(42)37(29-49)47(38)28-30-24-26-31(27-25-30)35-21-13-14-22-36(35)40-44-46-48(45-40)41(32-15-7-4-8-16-32,33-17-9-5-10-18-33)34-19-11-6-12-20-34/h4-22,24-27,29H,2-3,23,28H2,1H3
Synonym : Losartan Bromo N2-Trityl Impurity
Technical Data
Reference
Development and validation of a stability-indicating HPLC method for the simultaneous determination of Losartan potassium, hydrochlorothiazide, and their degradation products
Deanne L. Hertzog a,*, Jennifer Finnegan McCafferty b , Xueguang Fang b , R. Jeffrey Tyrrell c , Robert A. ReednJournal of Pharmaceutical and Biomedical Analysis 30 (2002) 747u2013760
An Efficient, Commercially Viable, and Safe Process for Preparation of Losartan Potassium, an Angiotensin II Receptor Antagonist
, Jennifer Finnegan McCafferty b , Xueguang Fang b , R. Jeffrey Tyrrell c , Robert A. Reed – Journal of Pharmaceutical and Biomedical Analysis 30 (2002) 747–760
Suri Babu Madasu,†,‡ N. A. Vekariya,
RFQ